The purpose of this grant is to furnish basic and clinical research training for postdoctoral renal fellows with M.D. or M.D./Ph.D. degrees that wish to pursue biomedical research careers. Trainees entering our research laboratories will usually have completed a medical residency and one year of clinical nephrology. Selection for appointment is based on the aptitude of the applicant and their commitment to a career in biomedical research. Trainees are normally appointed for two years. Our program teaches a rigorous approach to scientific inquiry in basic science or/and clinical investigation. The faculty of this training program are all members of the University of Pennsylvania. Together they form a close and well-integrated collaborative entity dedicated to research training and investigation. The core basic research program emphasizes the areas of immunology/inflammation, transplantation, kidney development and structural biology, whereas the core clinical research programs focus on the epidemiology of chronic kidney disease and hypertension, and health care economics. Trainees may elect to work with investigators outside the Renal Electrolyte and Hypertension Division, as long as they are working in renal-related areas. In either scenario, cross-fertilization and development of skills to prepare trainees for a life long investigative career are emphasized. Each trainee will develop a carefully crafted research project under the close supervision of a faculty trainer. This intensively structured research experience will be supplemented by research seminars, attendance at scientific meetings, and by formal course work in molecular genetics, immunology, biochemistry, cell biology, statistics, bioethics, environmental health, radiation safety and experimental design. The Renal Research Training Committee made up of the Program Directors will carefully monitor the evolving progress of each trainee. Upon completion of this comprehensive experience, it is anticipated that each graduate will be equipped to effectively compete for further individual training support, or for independent funding at an entry-level faculty position in academic nephrology.
Kidney disease is a leading cause of illness and death in the United States. This application is for a program to train young physicians to conduct research into developing new strategies and treatments for kidney disease.
|Bansal, Amar D; Negoianu, Dan; Warburton, Karen M (2016) An Unusual yet ""Mg""nificent Indication for Hemodialysis. Semin Dial :|
|Clark, Stephanie L; Denburg, Michelle R; Furth, Susan L (2016) Physical activity and screen time in adolescents in the chronic kidney disease in children (CKiD) cohort. Pediatr Nephrol 31:801-8|
|Chu, Carissa; Masic, Selma; Usawachintachit, Manint et al. (2016) Ultrasound-Guided Renal Access for Percutaneous Nephrolithotomy: A Description of Three Novel Ultrasound-Guided Needle Techniques. J Endourol 30:153-8|
|Harms Pritchard, Gretchen; Hall, Aisling O'Hara; Christian, David A et al. (2015) Diverse roles for T-bet in the effector responses required for resistance to infection. J Immunol 194:1131-40|
|Lin, Jennie; Zhang, Xuan; Xue, Chenyi et al. (2015) The long noncoding RNA landscape in hypoxic and inflammatory renal epithelial injury. Am J Physiol Renal Physiol 309:F901-13|
|Rodell, Christopher B; Rai, Reena; Faubel, Sarah et al. (2015) Local immunotherapy via delivery of interleukin-10 and transforming growth factor Î² antagonist for treatment of chronic kidney disease. J Control Release 206:131-9|
|Spinale, Joann M; Mariani, Laura H; Kapoor, Shiv et al. (2015) A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease. Kidney Int 87:564-74|
|Bansal, Amar D; Hill, Chloe E; Berns, Jeffrey S (2015) Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease. Semin Dial 28:404-12|
|Brown, J C; Harhay, M O; Harhay, M N (2015) Physical function as a prognostic biomarker among cancer survivors. Br J Cancer 112:194-8|
|Dupont, Christopher D; Harms Pritchard, Gretchen; Hidano, Shinya et al. (2015) Flt3 Ligand Is Essential for Survival and Protective Immune Responses during Toxoplasmosis. J Immunol 195:4369-77|
Showing the most recent 10 out of 188 publications